Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for VTE prevention after total hip arthroplasty
NCT01181167Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2009
- Primary completion
- Jan 2010
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of edoxaban in venous thromboembolism (VTE) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Incidence of Venous Thromboembolism Events at 2 weeks. Started May 2009; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01181167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181167.